The generation of transgenic mouse models with BFLS-like, T-ALL-like, or AML-like PHF6 mutations, will certainly augment the dissection of the molecular mechanisms driving BFLS and leukemia. The gene discussed is PHF6; the disease is acute lymphoblastic leukemia.